Urinary stones in HIV-1-positive patients treated with indinavir

Lancet. 1997 May 3;349(9061):1294-5. doi: 10.1016/s0140-6736(05)62506-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / pharmacokinetics
  • Anti-HIV Agents / therapeutic use
  • Female
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / pharmacokinetics
  • HIV Protease Inhibitors / therapeutic use
  • HIV Seropositivity / drug therapy*
  • HIV-1*
  • Humans
  • Indinavir / adverse effects*
  • Indinavir / pharmacokinetics
  • Indinavir / therapeutic use
  • Male
  • Middle Aged
  • Urinary Calculi / chemically induced*
  • Urinary Calculi / chemistry
  • Urinary Calculi / pathology

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Indinavir